-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
As of mid-2021, the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) virus has caused more than 200 million confirmed cases of coronavirus disease ( COVID-19 ) worldwide and killed more than 4.
As of mid-2021, the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) virus has caused more than 200 million confirmed cases of coronavirus disease ( COVID-19 ) worldwide and killed more than 4.
A total of 12,109 patients with IBD were included in the study, all of whom received 2 doses of the vaccine
Infect
This study demonstrated that the efficacy of the COVID-19 vaccine in IBD patients was comparable to that of non-IBD controls and was not affected by TNF inhibitor or corticosteroid treatment
This study demonstrated that the efficacy of the COVID-19 vaccine in IBD patients was comparable to that of non-IBD controls and was not affected by TNF inhibitor or corticosteroid treatment
Raffi Lev-Tzion.
COVID-19 Vaccine Is Effective in Inflammatory Bowel Disease Patients and Is Not Associated With Disease Exacerbation.
Leave a Comment
